Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer.
about
Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer.Impact of five-tiered Gleason grade groups on prognostic prediction in clinical stage T3 prostate cancer undergoing high-dose-rate brachytherapy.Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer.
P2860
Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Prostate-specific antigen nadi ...... in high-risk prostate cancer.
@en
Prostate-specific antigen nadi ...... in high-risk prostate cancer.
@nl
type
label
Prostate-specific antigen nadi ...... in high-risk prostate cancer.
@en
Prostate-specific antigen nadi ...... in high-risk prostate cancer.
@nl
prefLabel
Prostate-specific antigen nadi ...... in high-risk prostate cancer.
@en
Prostate-specific antigen nadi ...... in high-risk prostate cancer.
@nl
P2093
P2860
P356
P1476
Prostate-specific antigen nadi ...... in high-risk prostate cancer.
@en
P2093
Akane Sekiguchi
Hideyasu Tsumura
Hiromichi Ishiyama
Kazushige Hayakawa
Ken-Ichi Tabata
Masaomi Ikeda
Masashi Kitano
Masatsugu Iwamura
Shinji Kurosaka
Shouko Komori
P2860
P304
P356
10.5114/JCB.2016.59686
P577
2016-04-29T00:00:00Z